CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Constipation - Management
How should I manage short duration constipation in adults?
- Advise the person about lifestyle measures — increasing dietary fibre, drinking an adequate fluid intake, and exercise.
- Offer additional oral laxatives if dietary measures are ineffective, or while waiting for them to take effect.
- Start treatment with a bulk-forming laxative (adequate fluid intake is important).
- If stools remain hard, add or switch to an osmotic laxative.
- If stools are soft but the person still finds them difficult to pass or complains of inadequate emptying, add a stimulant laxative.
- Advise the person that laxatives can be stopped once the stools become soft and easily passed again.
Basis for recommendation
The literature tends to focus on chronic constipation and does not discuss the management of short duration constipation as a particular clinical problem, although it is common in primary care.
These recommendations therefore reflect what is commonly regarded as good practice in UK primary care.
- Dehydration, reduced levels of physical activity, and low levels of dietary fibre are associated with constipation. However, the clinical impression is that increasing fluids above an adequate daily intake, increasing exercise, and advice to increase dietary fibre does not always relieve constipation.
- For all laxatives, trial evidence on efficacy and safety is limited. This is mainly because these agents have been in use for a long time, clinical trials were far less robust at the time they were originally licensed, and few new clinical trials have been done.
© NHS Institute for Innovation and Improvement